BioSpace News Archive

Menarini Ricerche today announced the publication of the results of a non-clinical study describing the characterization of the anti-CD205 Antibody-Drug Conjugate (ADC) MEN1309/OBT076.

Seven Oncology Nursing Society members were included among the highly distinguished nurse leaders that the American Academy of Nursing announced as its class of 2019 fellows on June 18, 2019.

TridentUSA Health Services and Consulate Health Care announced a long-term partnership agreement to extend Trident’s radiology, ultrasound and laboratory services to all 140 of Consulate Health Care’s Senior Care facilities nationwide.

Just Biotherapeutics, Inc. (Just), an integrated design company focused on technologies for accelerating the development and manufacture of biotherapeutics, announced today that they have entered into an agreement with Teva for the design and development of a high productivity (HP) biomanufacturing process.

CorWave announced today that results from chronic preclinical studies to evaluate its Left Ventricular Assist Device (LVAD) will be presented at the 65th Annual Conference of the American Society for Artificial Internal Organs (ASAIO) in San Francisco.

Promedica International (PMI) and Dr. Agarwal’s Eye Hospitals (AEH) have formed a new partnership to conduct clinical trials in India, which they announced at the OCTANe Ophthalmology Technology Summit.

Ping An Insurance Company of China, Ltd. has received global recognition for its achievements in artificial intelligence processing of human language in the healthcare field.

Zoetis Inc. (NYSE:ZTS) will host a webcast and conference call at 8:30 a.m. (ET) on Tuesday, Aug. 6, 2019. Chief Executive Officer Juan Ramón Alaix and Executive Vice President and Chief Financial Officer Glenn David will review second quarter 2019 financial results and respond to questions from financial analysts during the call.

Dyne Therapeutics, a biotechnology company pioneering targeted therapies for patients with serious muscle diseases, today announced the appointment of Catherine Stehman-Breen, M.D., to its Board of Directors.

The Center for Reproductive Health & Gynecology has announced that it now offers the INVOCELL Intravaginal Culture (IVC) System in time for Pride Month. Dr. Sam Najmabadi, a Los Angeles-based fertility expert, is thrilled to provide the first-of-its-kind procedure, which comprises the INVOCELL Culture and Retention Devices.